Uganda is registering around 38,000 new infections despite the deployment of different interventions such as condoms and oral ...

Drug-resistance amino acids known in HIV-1 [36] are shown in bold. Amino acids that are the same as those of the reference HIV-1 HXB2 are shown as bars. † Consensus amino acid sequences were ...

Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in ...

A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...

Several giant US and international groups focused on fighting HIV and AIDS on Tuesday unveiled a plan to swiftly provide ...

Reports indicate that Cambodia plans to introduce Pre-Exposure Prophylaxis (PrEP) for HIV prevention by early 2025. However, ...

Lenacapavir, a preventive HIV drug, could become accessible in low-income countries by 2026. Efforts spearheaded by global ...

There are biological and clinical questions facing the field of HIV genotyping such as the need to better define the level of sensitivity required to detect drug-resistant variants, how different ...

WHILE South Africans now seem less concerned about HIV than in previous years, a young professor from the University of ...

By 2025, a new HIV preventive drug, lenacapavir, could be available to the world's poorest regions. The Global Fund aims to ...